JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "ATP Binding Cassette Transporter, Subfamily B, Member 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acute Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genes, MDR", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Myeloid, Acute", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Precursor Cell Lymphoblastic Leukemia-Lymphoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Failure", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Service d\u2019H\u00e9matologie Biologique de l\u2019H\u00f4tel-Dieu Formation de Recherche Associ\u00e9 Claude Bernard, Universit\u00e9 Paris VI. H\u00f4tel-Dieu, 75181, Paris Cedex 04, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Service d\u2019H\u00e9matologie Biologique de l\u2019H\u00f4tel-Dieu Formation de Recherche Associ\u00e9 Claude Bernard, Universit\u00e9 Paris VI. H\u00f4tel-Dieu, 75181, Paris Cedex 04, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Marie", 
        "givenName": "Jean-Pierre", 
        "id": "sg:person.01064502270.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064502270.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service d\u2019H\u00e9matologie Biologique de l\u2019H\u00f4tel-Dieu Formation de Recherche Associ\u00e9 Claude Bernard, Universit\u00e9 Paris VI. H\u00f4tel-Dieu, 75181, Paris Cedex 04, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Service d\u2019H\u00e9matologie Biologique de l\u2019H\u00f4tel-Dieu Formation de Recherche Associ\u00e9 Claude Bernard, Universit\u00e9 Paris VI. H\u00f4tel-Dieu, 75181, Paris Cedex 04, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Legrand", 
        "givenName": "Ollivier", 
        "id": "sg:person.0752753564.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752753564.08"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1999", 
    "datePublishedReg": "1999-01-01", 
    "description": "P-glycoprotein (P-gp) is often expressed (40\u201350%) on leukemic cells at diagnosis in acute myelogenous leukemia (AML), and is even more frequently present after treatment failure. Several large cohorts of newly diagnosed AML patients treated with a classical anthracycline + standard doses of cytosine arabinoside were tested for the prognosis value of MDR1 phenotype, and demonstrated an high correlation between a significant increase of MDR1 gene expression and treatment failure (or, better, drug resistance).This P-gp(+) drug resistance could be due either to a particular phenotype of bad prognosis AML, as it is suggested by the association of myelodysplasia, complex karyo-type and advanced age with MDR1 phenotype, or due primarily to the active efflux of anthracyclines and VP16 in P-gp (+) leukemic cells. Several observations tend to confirm the functional role of the P-gp in clinical drug resistance: (i) using multivariate analysis, MDR1 phenotype appears to be an independent variable, as potent (or higher) as karyo-type and age for predicting in vivo drug resistance; (ii) the prognostic value is limited to the CD34(+)/P-gp(+) phenotype, wich is linked to a functional P-gp; (iii) the in vitro sensitivity to anthracyclines and VP16 is highly correlated with P-gp expression. All these data argue for an early use of P-gp modifier agents in the treatment of AML.The role of the MDR1 gene in ALL resistance is controversial and marginal compared to the sensitivity of ALL blasts to glucocorticoids, and the frequency of MDR1 phenotype is low at diagnosis, and is increasing only after repetitive chemotherapies.", 
    "editor": [
      {
        "familyName": "Kaspers", 
        "givenName": "G. J. L.", 
        "type": "Person"
      }, 
      {
        "familyName": "Pieters", 
        "givenName": "R.", 
        "type": "Person"
      }, 
      {
        "familyName": "Veerman", 
        "givenName": "A. J. P.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4615-4811-9_1", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4613-7180-9", 
        "978-1-4615-4811-9"
      ], 
      "name": "Drug Resistance in Leukemia and Lymphoma III", 
      "type": "Book"
    }, 
    "keywords": [
      "acute myelogenous leukemia", 
      "MDR1 phenotype", 
      "drug resistance", 
      "treatment failure", 
      "gp expression", 
      "leukemic cells", 
      "treatment of AML", 
      "vivo drug resistance", 
      "MDR1/P", 
      "clinical drug resistance", 
      "MDR1 gene expression", 
      "repetitive chemotherapy", 
      "standard doses", 
      "prognostic factors", 
      "AML patients", 
      "prognostic value", 
      "acute leukemia", 
      "advanced age", 
      "large cohort", 
      "myelogenous leukemia", 
      "prognosis value", 
      "multivariate analysis", 
      "MDR1 gene", 
      "early use", 
      "classical anthracyclines", 
      "anthracyclines", 
      "significant increase", 
      "active efflux", 
      "leukemia", 
      "diagnosis", 
      "phenotype", 
      "age", 
      "functional role", 
      "GPs", 
      "expression", 
      "gene expression", 
      "cells", 
      "chemotherapy", 
      "patients", 
      "myelodysplasia", 
      "failure", 
      "particular phenotype", 
      "glucocorticoids", 
      "cohort", 
      "doses", 
      "VP16", 
      "treatment", 
      "resistance", 
      "high correlation", 
      "role", 
      "association", 
      "efflux", 
      "independent variables", 
      "sensitivity", 
      "glycoprotein", 
      "agents", 
      "blasts", 
      "factors", 
      "genes", 
      "increase", 
      "correlation", 
      "cytosine", 
      "use", 
      "frequency", 
      "values", 
      "data", 
      "variables", 
      "analysis", 
      "modifier agent", 
      "observations", 
      "wich"
    ], 
    "name": "MDR1/P-GP Expression as A Prognostic Factor in Acute Leukemias", 
    "pagination": "1-9", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1050675331"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4615-4811-9_1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10500774"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4615-4811-9_1", 
      "https://app.dimensions.ai/details/publication/pub.1050675331"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-06-01T22:33", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/chapter/chapter_363.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-4615-4811-9_1"
  }
]

Download the RDF metadata as:  json-ld nt turtle xml License info

This table displays all metadata directly associated to this object as RDF triples.

200 TRIPLES      23 PREDICATES      110 URIs      103 LITERALS      20 BLANK NODES